Chih-Hwa Wallace Lin, Senior Researcher, Director, Division of Resource Development, Center for Drug Evaluation (CDE) Tawian, speaks to Andrea Charles from Pharma IQ, about streamlining the clinical trial process and reducing approval time. In this interview they discuss which new guidelines are likely to impact pharma/bio companies in 2011/2012, how the relationship between China and Taiwan will evolve and recommendations for entry into the Taiwanese paharmaceutical market.
Interview with Chih-Hwa Wallace Lin, Center for Drug Evaluation Taiwan
Pharmaceuticals & Biotechnology Editor | 09/27/2011